GlassScriptPhysician profile
Tyler Russell Archer
NPI 1548770944
$2,193.89
in general payments reported to CMS, 2019-2025
22 companies · $491 in 2025
The $491 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $196 · 2022: $598 · 2023: $413 · 2024: $496 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,400.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $656.17 | 2022-2025 | Relistor, Xifaxan |
| Boston Scientific Corporation | $417.79 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Scilex Pharmaceuticals INC. | $178.86 | 2021-2024 | Ztlido |
| Medtronic, INC. | $169.36 | 2022-2025 | Kyphon Express II Kyphopak Tray, Inceptiv, Accurian |
| Collegium Pharmaceutical, INC. | $114.25 | 2021-2025 | Belbuca, Xtampza |
| Nalu Medical, INC. | $97.93 | 2023-2024 | Nalu Neurostimulation System |
| Curonix LLC | $70.03 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Grt US Holding, INC. | $69.32 | 2021-2022 | |
| Saluda Medical Americas, INC. | $60.21 | 2024-2025 | Evoke |
| Nevro Corp. | $49.62 | 2023-2024 | Senza |
| Arbor Pharmaceuticals, INC. | $43.44 | 2021 | |
| Vertos Medical, INC. | $39.01 | 2023-2024 | Mild Device Kit |
| Virtus Pharmaceuticals LLC | $36.48 | 2021 | |
| Abbvie INC. | $31.47 | 2022 | |
| Hikma Pharmaceuticals USA | $29.45 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $28.71 | 2022 | |
| Stryker Corporation | $23.36 | 2024 | Mild Device Kit |
| Painteq LLC | $19.60 | 2024 | Painteq |
| Fidia Pharma USA INC. | $18.81 | 2023 | Hymovis, Triluron |
| Orthofix Medical, INC. | $14.02 | 2021 | |
| Ibsa Pharma INC. | $13.80 | 2023 | Tirosint, Licart |
| Stimwave Technologies Incorporated | $12.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Archer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.